The Effect of Intranasal Olopatadine Hydrochloride on Influenza A and B Symptoms In Children: A Clinical Observation and Comparative Evaluation
Yazarlar (2)
Vefik Arıca Sağlık Bilimleri Üniversitesi, Türkiye
Dr. Öğr. Üyesi Taner ADIGÜZEL Yalova Üniversitesi, Türkiye
| Makale Türü | Özgün Makale (Diğer hakemli uluslarası dergilerde yayınlanan tam makale) | ||
| Dergi Adı | Chron Precis Med Res | ||
| Dergi ISSN | 2757-6124 | ||
| Dergi Tarandığı Indeksler | Index Copernicus, OpenAIRE, Google Scholar and EuroPub | ||
| Makale Dili | İngilizce | Basım Tarihi | 07-2025 |
| Cilt / Sayı / Sayfa | 6 / 2 / 48–51 | DOI | 10.5281/zenodo.16585082 |
| Makale Linki | https://chronpmr.com/index.php/cpmr/issue/view/30 | ||
| UAK Araştırma Alanları |
Çocuk Sağlığı ve Hastalıkları (Çocuk Sağlığı ve Hastalıkları)
|
||
| Özet |
| Aim: This study aims to evaluate the effects of intranasal Olopatadine Hydrochloride on nasal and systemic symptoms in pediatric patients diagnosed with influenza A or B infection. Material and Method: Children aged 6-18 years who presented to the Pediatric Outpatient Clinics of Health Sciences University Prof. Dr. Cemil Taşcıoğlu City Hospital and Yalova Training and Research Hospital between 1 January and 15 March 2025 and were diagnosed with influenza A or B were retrospectively evaluated. Patients (n= 50) who received appropriately dosed intranasal Olopatadine Hydrochloride alongside symptomatic treatment underwent face-to-face interviews regarding their previous treatment experience, including symptom profiles and duration.Results: In the influenza A-positive group (n= 25), the duration of nasal congestion was 2 days in the group receiving intranasal Olopatadine Hydrochloride (n= 13) versus 6 days in the group receiving no Olopatadine Hydrochloride (n= 12). Sneezing lasted 1 day in the Olopatadine group and 7 days in the group receiving no Olopatadine. No significant differences were observed in systemic symptoms. A significant reduction in the duration of nasal congestion and sneezing was observed in the Olopatadine group (p< 0.001). In the influenza B-positive group (n= 25), nasal congestion lasted 1 day in the Olopatadine group (n= 13) and 3 days in the other group (n= 12). Sneezing lasted 1 day in the Olopatadine group and 4 days in the other. Again, there were no significant differences in systemic symptoms. A significant reduction in nasal congestion and sneezing duration was observed in the Olopatadine … |
| Anahtar Kelimeler |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Yöksis | 3 |
| Google Scholar | 3 |